🇺🇸 FDA
Pipeline program

Cardiovascular drugs strategies

CNGE20060702

Approved other completed

Quick answer

Cardiovascular drugs strategies for High Risk Hypertensive Patients is a Approved program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
High Risk Hypertensive Patients
Phase
Approved
Modality
other
Status
completed

Clinical trials